The Intravenous Glucose Tolerance Test in Malignant Disease
1962

Intravenous Glucose Tolerance Test in Cancer Patients

Sample size: 37 publication Evidence: moderate

Author Information

Author(s): D. H. A. Boyd, Brigid Clapp, Maureen Finnegan

Primary Institution: Department for Endocrine and Metabolic Disease, Western General Hospital, Edinburgh

Hypothesis

The study aims to assess the incidence and severity of carbohydrate metabolism disorders in malignant disease and the effect of treatment on these abnormalities.

Conclusion

The study found that 50% of cancer patients had diminished glucose tolerance, which improved after treatment with oestrogens.

Supporting Evidence

  • 50% of cancer patients showed diminished glucose tolerance.
  • After treatment with oestrogens, glucose tolerance improved in six patients.
  • The study compared results with previous studies showing varying rates of glucose tolerance issues in cancer patients.

Takeaway

Some cancer patients have trouble processing sugar, but treatment can help them get better at it.

Methodology

The study involved two groups: 19 control patients and 18 cancer patients, with glucose tolerance tests performed before and after treatment.

Potential Biases

Potential biases may arise from the small number of cases and the specific types of cancer studied.

Limitations

The study had a relatively small sample size and may not represent all cancer patients.

Participant Demographics

The study included 19 control patients and 18 patients with recurrent or metastatic mammary carcinoma, all at least five years past menopause.

Statistical Information

P-Value

0.01-0.005

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication